Gastroduodenal Peptic Ulcers: A Comprehensive Overview
Definition and Pathophysiology
Gastroduodenal peptic ulcers are mucosal defects that extend through the muscularis mucosae into the submucosa, occurring when aggressive factors (acid and pepsin) overwhelm protective mucosal defense mechanisms. 1
The pathophysiology differs between gastric and duodenal ulcers:
Duodenal ulcers typically occur with H. pylori infection causing duodenitis, often accompanied by impaired duodenal bicarbonate secretion despite normal or moderately increased acid secretion. The bacteria colonize areas of gastric metaplasia in the duodenum, triggering inflammation that disrupts mucosal defense and regeneration 2
Gastric ulcers usually develop with normal or decreased acid-peptic activity, suggesting that breakdown of defensive factors is the primary mechanism, allowing damage from both endogenous and exogenous aggressive factors 2, 3
Epidemiology and Clinical Significance
In the United States, peptic ulcer disease affects 1% of the population, with approximately 54,000 hospital admissions annually for bleeding peptic ulcers. Approximately 10% of patients presenting with upper abdominal pain in primary care have peptic ulcers, and the disease causes 10,000 deaths annually 4
Notably, approximately two-thirds of patients with peptic ulcer disease are asymptomatic 1
Etiology
The two principal causes are:
- Helicobacter pylori infection - affects approximately 42% of patients with peptic ulcer disease 4
- NSAID/aspirin use - accounts for approximately 36% of cases 4
With the aging population, H. pylori-related cases are declining while drug-induced ulcers are increasing 5
Clinical Presentation
In symptomatic patients, the most common presenting symptom is epigastric pain, which may be associated with:
- Dyspepsia
- Bloating
- Abdominal fullness
- Nausea
- Early satiety 1
Important caveat: Pain can disappear without complete ulcer healing, and ulcers can be present without pain, particularly in elderly patients and those taking ulcerogenic medications 6
Complications
The major complications and their relative frequencies are:
- Bleeding - 73% of complicated cases
- Perforation - 9% of complicated cases
- Pyloric obstruction - 3% of complicated cases 4
Diagnosis
Endoscopy is the definitive diagnostic method for peptic ulcer disease 4
All patients with peptic ulcers should be tested for H. pylori infection 7, 8. However, most tests for active infection may show increased false-negative rates during acute bleeding 7. The optimal approach includes acute testing followed by confirmatory testing outside the acute bleeding context if initial results are negative.
Treatment
Acid Suppression
Proton pump inhibitors (PPIs) are the primary treatment, healing 80-100% of peptic ulcers within 4 weeks 4. However, gastric ulcers larger than 2 cm may require 8 weeks of treatment 4
H. pylori Eradication
For treatment-naive patients with H. pylori infection, bismuth quadruple therapy (BQT) for 14 days is the preferred regimen when antibiotic susceptibility is unknown 9
Eradication of H. pylori dramatically reduces ulcer recurrence rates from approximately 50-60% to 0-2% 4. Post-treatment H. pylori infection status is an independent predictor of rebleeding 7
NSAID-Related Ulcers
When NSAIDs are the cause, discontinuing them heals 95% of ulcers and reduces recurrence from 40% to 9% 4
For patients with a history of peptic ulcers who require NSAIDs or aspirin, H. pylori eradication is mandatory before starting NSAID treatment 8
When discontinuing NSAIDs is not possible, the following strategies reduce recurrence:
- Switching to a less ulcerogenic NSAID (e.g., from ketorolac to ibuprofen)
- Adding a PPI such as omeprazole or lansoprazole
- Eradicating H. pylori if present 4
For aspirin users with a history of gastroduodenal ulcer, testing for H. pylori should be performed, and the long-term incidence of peptic ulcer bleeding is low after successful eradication even without gastroprotective treatment 8
Long-term PPI Use Considerations
Long-term PPI treatment in H. pylori-positive patients is associated with corpus-predominant gastritis and progression to atrophic gastritis 8. Eradication of H. pylori in patients receiving long-term PPIs heals gastritis and prevents progression to atrophic gastritis, though there is no evidence this reduces gastric cancer risk 8
Management of Bleeding Peptic Ulcers
For patients with upper GI bleeding from peptic ulcers:
- Endoscopic hemostasis is the first-line treatment 5
- Vital signs should be stabilized before and after endoscopic hemostasis with appropriate severity assessment 5
- Patients at low risk for rebleeding after endoscopy can be fed within 24 hours 7
- Patients with low-risk endoscopic findings (clean base, flat spot, or clot) may be discharged immediately after stabilization 7